{
    "2018-07-10": [
        [
            {
                "time": "2018-07-16",
                "original_text": "【东吴医药】智飞生物事件点评-五价轮状病毒疫苗签订采购协议超预期，为公司业绩增长贡献增量",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "五价轮状病毒疫苗",
                        "采购协议",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "中报行情全面爆发！三类股摇钱有“术”……",
                "features": {
                    "keywords": [
                        "中报行情",
                        "三类股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "智飞生物：冻干人用狂犬病疫苗获临床试验批件",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "冻干人用狂犬病疫苗",
                        "临床试验批件"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "[看好评级]医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点关注稳健成长和“流量入口”型公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩前瞻",
                        "医疗需求刚性",
                        "稳健成长",
                        "流量入口型公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "[推荐评级]医药生物行业中报业绩前瞻：重点覆盖公司中报业绩前瞻：关注2季度增速加快个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩前瞻",
                        "2季度增速加快"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "两大逻辑促疫苗股飙升 4只白马股备受机构青睐",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "飙升",
                        "白马股",
                        "机构青睐"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "智飞生物涨0.68%，创近1个月新高，报49.00元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "涨0.68%",
                        "新高",
                        "49.00元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "两大逻辑促疫苗股飙升 6只白马股备受机构青睐",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "飙升",
                        "白马股",
                        "机构青睐"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "医药行业周报:《我不是药神》引热议,持续看好创新药板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "我不是药神",
                        "创新药板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "智飞生物:轮状疫苗签署补充协议,确定基础采购计划",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "轮状疫苗",
                        "补充协议",
                        "基础采购计划"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}